Gelonghui August 30?Guangji Pharmaceutical (000952.SZ) released its semi-annual report for 2023, with operating income of 344 million yuan for the reporting period, down 8.54% from the same period last year; net profit belonging to shareholders of listed companies was-25.8045 million yuan, turning to profit and loss compared with the same period last year; net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was-27.4153 million yuan; basic earnings per share was-0.0729 yuan.
广济药业(000952.SZ)：上半年净亏损2580.45万元
Guangji Pharmaceutical (000952.SZ): Net loss of 258.045 million yuan in the first half of the year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.